Perinatal and neonatal outcomes for fetoscopic laser ablation for the treatment of twin twin transfusion syndrome at a single center

Authors

Diamond Ling, Advocate Aurora Health
Alexandra Phelps, Advocate Aurora Health
Tabitha Tate, Advocate Aurora Health
James Adefisoye, Advocate Aurora HealthFollow
Suwan Mehra, Advocate Aurora HealthFollow
Preetha Prazad, Advocate Aurora HealthFollow

Recommended Citation

Ling D, Phelps A, Tate T, Adefisoye J, Mehra S, Prazad P. Perinatal and neonatal outcomes for fetoscopic laser ablation for the treatment of twin twin transfusion syndrome at a single center. J Perinatol. 2023;43(2):147-154. doi:10.1038/s41372-022-01568-2

Affiliations

Advocate Children's Hospital, Advocate Lutheran General Hospital, Aurora Sinai Medical Center

Abstract

Objective: To describe the perinatal and neonatal outcomes of fetal laser ablation (FLA) for the treatment of twin-twin transfusion syndrome (TTTS) in our single center institution.

Study design: Retrospective study of 76 treated pregnant women. Procedural complications, perinatal and neonatal outcomes analyzed. Differences in outcomes between two procedural techniques, selective and Solomon, compared.

Results: FLA occurred at median gestational age (GA) of 20.8 weeks (IQR 18.1-22.9) with low incidence of procedural complications (5.3%). High survival rate with delivery of at least one neonate (96%) [95% CI: 88.9-99.2%]; 73.7% [95% CI: 62.3-83.1%] were twins. Median GA at birth was 33.1 weeks (IQR 28.0-35.0). Neonatal mortality and morbidities were 9.4% and 48.3% of cases respectively, and associated with lower GA. Solomon cases had comparatively higher median GA, and lower incidences of neonatal morbidities.

Conclusion: Our small single center study showed favorable outcomes for using the Solomon technique in the treatment of TTTS.

Type

Article

PubMed ID

36473930